APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drugs for Sexual Dysfunction

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Drugs for Sexual Dysfunction Market Analysis and Forecast 2026-2032

29 December 2025205 pages

Choose your research edition.

Industry ResearchDrugs for Sexual Dysfunction Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Drugs for Sexual Dysfunction Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Drugs for Sexual Dysfunction Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drugs for Sexual Dysfunction Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Drugs for Sexual Dysfunction Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Drugs for Sexual Dysfunction market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Drugs for Sexual Dysfunction is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Drugs for Sexual Dysfunction is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Drugs for Sexual Dysfunction is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Drugs for Sexual Dysfunction is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Drugs for Sexual Dysfunction include Boston Scientific Corporation, CSBio, Dong-A ST, General Factory, Hims, Lilly ICOS LLC, Lupin, Meda Pharmaceuticals and Menarini Group, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Drugs for Sexual Dysfunction, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Drugs for Sexual Dysfunction, also provides the sales of main regions and countries. Of the upcoming market potential for Drugs for Sexual Dysfunction, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Drugs for Sexual Dysfunction sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Drugs for Sexual Dysfunction market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Drugs for Sexual Dysfunction sales, projected growth trends, production technology, application and end-user industry.

Drugs for Sexual Dysfunction Segment by Company

Boston Scientific Corporation

CSBio

Dong-A ST

General Factory

Hims

Lilly ICOS LLC

Lupin

Meda Pharmaceuticals

Menarini Group

Metuchen Pharma

SK Chemicals.

Vivus, Inc.

Bayer AG

Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.

Pfizer Inc

Lilly

Sanofi

Teva Pharmaceutical Industries Ltd.

Drugs for Sexual Dysfunction Segment by Type

Vardenafil (Levitra, Staxyn)

Tadalafil (Cialis)

Udenafil (Zydena)

Sildenafil (Viagra)

Others

Drugs for Sexual Dysfunction Segment by Application

Retail Pharmacies

Online Pharmacies

Hospitals

Clinics

Drugs for Sexual Dysfunction Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for Sexual Dysfunction market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drugs for Sexual Dysfunction and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for Sexual Dysfunction.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Drugs for Sexual Dysfunction in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Drugs for Sexual Dysfunction manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drugs for Sexual Dysfunction sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drugs for Sexual Dysfunction Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Vardenafil (Levitra, Staxyn) Major Manufacturers Table 3. Tadalafil (Cialis) Major Manufacturers Table 4. Udenafil (Zydena) Major Manufacturers Table 5. Sildenafil (Viagra) Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Drugs for Sexual Dysfunction Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Retail Pharmacies Major Manufacturers Table 9. Online Pharmacies Major Manufacturers Table 10. Hospitals Major Manufacturers Table 11. Clinics Major Manufacturers Table 12. Drugs for Sexual Dysfunction Industry Trends Table 13. Drugs for Sexual Dysfunction Industry Drivers Table 14. Drugs for Sexual Dysfunction Industry Opportunities and Challenges Table 15. Drugs for Sexual Dysfunction Industry Restraints Table 16. Global Drugs for Sexual Dysfunction Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Drugs for Sexual Dysfunction Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Drugs for Sexual Dysfunction Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Drugs for Sexual Dysfunction Revenue Market Share by Region (2021-2026) Table 20. Global Drugs for Sexual Dysfunction Revenue Market Share by Region (2027-2032) Table 21. Global Drugs for Sexual Dysfunction Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Units) Table 22. Global Drugs for Sexual Dysfunction Sales by Region (2021-2026) & (Units) Table 23. Global Drugs for Sexual Dysfunction Sales by Region (2027-2032) & (Units) Table 24. Global Drugs for Sexual Dysfunction Sales Market Share by Region (2021-2026) Table 25. Global Drugs for Sexual Dysfunction Sales Market Share by Region (2027-2032) Table 26. Global Drugs for Sexual Dysfunction Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Drugs for Sexual Dysfunction Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Drugs for Sexual Dysfunction Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Drugs for Sexual Dysfunction Sales Market Share by Manufacturers (2021-2026) Table 30. Global Drugs for Sexual Dysfunction Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 31. Global Drugs for Sexual Dysfunction Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Drugs for Sexual Dysfunction Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Drugs for Sexual Dysfunction Manufacturers, Product Type & Application Table 34. Global Drugs for Sexual Dysfunction Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Drugs for Sexual Dysfunction by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Drugs for Sexual Dysfunction Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Drugs for Sexual Dysfunction Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Drugs for Sexual Dysfunction Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Drugs for Sexual Dysfunction Revenue Market Share by Type (2021-2026) Table 41. Global Drugs for Sexual Dysfunction Revenue Market Share by Type (2027-2032) Table 42. Global Drugs for Sexual Dysfunction Sales by Type 2021 VS 2025 VS 2032 (Units) Table 43. Global Drugs for Sexual Dysfunction Sales by Type (2021-2026) & (Units) Table 44. Global Drugs for Sexual Dysfunction Sales by Type (2027-2032) & (Units) Table 45. Global Drugs for Sexual Dysfunction Sales Market Share by Type (2021-2026) Table 46. Global Drugs for Sexual Dysfunction Sales Market Share by Type (2027-2032) Table 47. Global Drugs for Sexual Dysfunction Price by Type (2021-2026) & (US$/Unit) Table 48. Global Drugs for Sexual Dysfunction Price by Type (2027-2032) & (US$/Unit) Table 49. Global Drugs for Sexual Dysfunction Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Drugs for Sexual Dysfunction Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Drugs for Sexual Dysfunction Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Drugs for Sexual Dysfunction Revenue Market Share by Application (2021-2026) Table 53. Global Drugs for Sexual Dysfunction Revenue Market Share by Application (2027-2032) Table 54. Global Drugs for Sexual Dysfunction Sales by Application 2021 VS 2025 VS 2032 (Units) Table 55. Global Drugs for Sexual Dysfunction Sales by Application (2021-2026) & (Units) Table 56. Global Drugs for Sexual Dysfunction Sales by Application (2027-2032) & (Units) Table 57. Global Drugs for Sexual Dysfunction Sales Market Share by Application (2021-2026) Table 58. Global Drugs for Sexual Dysfunction Sales Market Share by Application (2027-2032) Table 59. Global Drugs for Sexual Dysfunction Price by Application (2021-2026) & (US$/Unit) Table 60. Global Drugs for Sexual Dysfunction Price by Application (2027-2032) & (US$/Unit) Table 61. Boston Scientific Corporation Company Information Table 62. Boston Scientific Corporation Business Overview Table 63. Boston Scientific Corporation Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Boston Scientific Corporation Drugs for Sexual Dysfunction Product Portfolio Table 65. Boston Scientific Corporation Recent Development Table 66. CSBio Company Information Table 67. CSBio Business Overview Table 68. CSBio Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. CSBio Drugs for Sexual Dysfunction Product Portfolio Table 70. CSBio Recent Development Table 71. Dong-A ST Company Information Table 72. Dong-A ST Business Overview Table 73. Dong-A ST Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Dong-A ST Drugs for Sexual Dysfunction Product Portfolio Table 75. Dong-A ST Recent Development Table 76. General Factory Company Information Table 77. General Factory Business Overview Table 78. General Factory Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. General Factory Drugs for Sexual Dysfunction Product Portfolio Table 80. General Factory Recent Development Table 81. Hims Company Information Table 82. Hims Business Overview Table 83. Hims Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Hims Drugs for Sexual Dysfunction Product Portfolio Table 85. Hims Recent Development Table 86. Lilly ICOS LLC Company Information Table 87. Lilly ICOS LLC Business Overview Table 88. Lilly ICOS LLC Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Lilly ICOS LLC Drugs for Sexual Dysfunction Product Portfolio Table 90. Lilly ICOS LLC Recent Development Table 91. Lupin Company Information Table 92. Lupin Business Overview Table 93. Lupin Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Lupin Drugs for Sexual Dysfunction Product Portfolio Table 95. Lupin Recent Development Table 96. Meda Pharmaceuticals Company Information Table 97. Meda Pharmaceuticals Business Overview Table 98. Meda Pharmaceuticals Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Meda Pharmaceuticals Drugs for Sexual Dysfunction Product Portfolio Table 100. Meda Pharmaceuticals Recent Development Table 101. Menarini Group Company Information Table 102. Menarini Group Business Overview Table 103. Menarini Group Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Menarini Group Drugs for Sexual Dysfunction Product Portfolio Table 105. Menarini Group Recent Development Table 106. Metuchen Pharma Company Information Table 107. Metuchen Pharma Business Overview Table 108. Metuchen Pharma Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Metuchen Pharma Drugs for Sexual Dysfunction Product Portfolio Table 110. Metuchen Pharma Recent Development Table 111. SK Chemicals. Company Information Table 112. SK Chemicals. Business Overview Table 113. SK Chemicals. Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. SK Chemicals. Drugs for Sexual Dysfunction Product Portfolio Table 115. SK Chemicals. Recent Development Table 116. Vivus, Inc. Company Information Table 117. Vivus, Inc. Business Overview Table 118. Vivus, Inc. Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Vivus, Inc. Drugs for Sexual Dysfunction Product Portfolio Table 120. Vivus, Inc. Recent Development Table 121. Bayer AG Company Information Table 122. Bayer AG Business Overview Table 123. Bayer AG Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Bayer AG Drugs for Sexual Dysfunction Product Portfolio Table 125. Bayer AG Recent Development Table 126. Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Company Information Table 127. Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Business Overview Table 128. Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Drugs for Sexual Dysfunction Product Portfolio Table 130. Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Recent Development Table 131. Pfizer Inc Company Information Table 132. Pfizer Inc Business Overview Table 133. Pfizer Inc Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Pfizer Inc Drugs for Sexual Dysfunction Product Portfolio Table 135. Pfizer Inc Recent Development Table 136. Lilly Company Information Table 137. Lilly Business Overview Table 138. Lilly Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Lilly Drugs for Sexual Dysfunction Product Portfolio Table 140. Lilly Recent Development Table 141. Sanofi Company Information Table 142. Sanofi Business Overview Table 143. Sanofi Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Sanofi Drugs for Sexual Dysfunction Product Portfolio Table 145. Sanofi Recent Development Table 146. Teva Pharmaceutical Industries Ltd. Company Information Table 147. Teva Pharmaceutical Industries Ltd. Business Overview Table 148. Teva Pharmaceutical Industries Ltd. Drugs for Sexual Dysfunction Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Teva Pharmaceutical Industries Ltd. Drugs for Sexual Dysfunction Product Portfolio Table 150. Teva Pharmaceutical Industries Ltd. Recent Development Table 151. North America Drugs for Sexual Dysfunction Revenue by Type (2021-2026) & (US$ Million) Table 152. North America Drugs for Sexual Dysfunction Revenue by Type (2027-2032) & (US$ Million) Table 153. North America Drugs for Sexual Dysfunction Sales by Type (2021-2026) & (Units) Table 154. North America Drugs for Sexual Dysfunction Sales by Type (2027-2032) & (Units) Table 155. North America Drugs for Sexual Dysfunction Sales Price by Type (2021-2026) & (US$/Unit) Table 156. North America Drugs for Sexual Dysfunction Sales Price by Type (2027-2032) & (US$/Unit) Table 157. North America Drugs for Sexual Dysfunction Revenue by Application (2021-2026) & (US$ Million) Table 158. North America Drugs for Sexual Dysfunction Revenue by Application (2027-2032) & (US$ Million) Table 159. North America Drugs for Sexual Dysfunction Sales by Application (2021-2026) & (Units) Table 160. North America Drugs for Sexual Dysfunction Sales by Application (2027-2032) & (Units) Table 161. North America Drugs for Sexual Dysfunction Sales Price by Application (2021-2026) & (US$/Unit) Table 162. North America Drugs for Sexual Dysfunction Sales Price by Application (2027-2032) & (US$/Unit) Table 163. North America Drugs for Sexual Dysfunction Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. North America Drugs for Sexual Dysfunction Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 165. North America Drugs for Sexual Dysfunction Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 166. North America Drugs for Sexual Dysfunction Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 167. North America Drugs for Sexual Dysfunction Sales by Country (2021-2026) & (Units) Table 168. North America Drugs for Sexual Dysfunction Sales by Country (2027-2032) & (Units) Table 169. North America Drugs for Sexual Dysfunction Sales Price by Country (2021-2026) & (US$/Unit) Table 170. North America Drugs for Sexual Dysfunction Sales Price by Country (2027-2032) & (US$/Unit) Table 171. United States Drugs for Sexual Dysfunction Revenue (2021-2032) & (US$ Million) Table 172. Canada Drugs for Sexual Dysfunction Revenue (2021-2032) & (US$ Million) Table 173. Mexico Drugs for Sexual Dysfunction Revenue (2021-2032) & (US$ Million) Table 174. Europe Drugs for Sexual Dysfunction Revenue by Type (2021-2026) & (US$ Million) Table 175. Europe Drugs for Sexual Dysfunction Revenue by Type (2027-2032) & (US$ Million) Table 176. Europe Drugs for Sexual Dysfunction Sales by Type (2021-2026) & (Units) Table 177. Europe Drugs for Sexual Dysfunction Sales by Type (2027-2032) & (Units) Table 178. Europe Drugs for Sexual Dysfunction Sales Price by Type (2021-2026) & (US$/Unit) Table 179. Europe Drugs for Sexual Dysfunction Sales Price by Type (2027-2032) & (US$/Unit) Table 180. Europe Drugs for Sexual Dysfunction Revenue by Application (2021-2026) & (US$ Million) Table 181. Europe Drugs for Sexual Dysfunction Revenue by Application (2027-2032) & (US$ Million) Table 182. Europe Drugs for Sexual Dysfunction Sales by Application (2021-2026) & (Units) Table 183. Europe Drugs for Sexual Dysfunction Sales by Application (2027-2032) & (Units) Table 184. Europe Drugs for Sexual Dysfunction Sales Price by Application (2021-2026) & (US$/Unit) Table 185. Europe Drugs for Sexual Dysfunction Sales Price by Application (2027-2032) & (US$/Unit) Table 186. Europe Drugs for Sexual Dysfunction Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 187. Europe Drugs for Sexual Dysfunction Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 188. Europe Drugs for Sexual Dysfunction Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 189. Europe Drugs for Sexual Dysfunction Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 190. Europe Drugs for Sexual Dysfunction Sales by Country (2021-2026) & (Units) Table 191. Europe Drugs for Sexual Dysfunction Sales by Country (2027-2032) & (Units) Table 192. Europe Drugs for Sexual Dysfunction Sales Price by Country (2021-2026) & (US$/Unit) Table 193. Europe Drugs for Sexual Dysfunction Sales Price by Country (2027-2032) & (US$/Unit) Table 194. Germany Drugs for Sexual Dysfunction Revenue (2021-2032) & (US$ Million) Table 195. France Drugs for Sexual Dysfunction Revenue (2021-2032) & (US$ Million) Table 196. U.K. Drugs for Sexual Dysfunction Revenue (2021-2032) & (US$ Million) Table 197. Italy Drugs for Sexual Dysfunction Revenue (2021-2032) & (US$ Million) Table 198. Russia Drugs for Sexual Dysfunction Revenue (2021-2032) & (US$ Million) Table 199. Spain Drugs for Sexual Dysfunction Revenue (2021-2032) & (US$ Million) Table 200. Netherlands Drugs for Sexual Dysfunction Revenue (2021-2032) & (US$ Million) Table 201. Switzerland Drugs for Sexual Dysfunction Revenue (2021-2032) & (US$ Million) Table 202. Sweden Drugs for Sexual Dysfunction Revenue (2021-2032) & (US$ Million) Table 203. Poland Drugs for Sexual Dysfunction Revenue (2021-2032) & (US$ Million) Table 204. China Drugs for Sexual Dysfunction Revenue by Type (2021-2026) & (US$ Million) Table 205. China Drugs for Sexual Dysfunction Revenue by Type (2027-2032) & (US$ Million) Table 206. China Drugs for Sexual Dysfunction Sales by Type (2021-2026) & (Units) Table 207. China Drugs for Sexual Dysfunction Sales by Type (2027-2032) & (Units) Table 208. China Drugs for Sexual Dysfunction Sales Price by Type (2021-2026) & (US$/Unit) Table 209. China Drugs for Sexual Dysfunction Sales Price by Type (2027-2032) & (US$/Unit) Table 210. China Drugs for Sexual Dysfunction Revenue by Application (2021-2026) & (US$ Million) Table 211. China Drugs for Sexual Dysfunction Revenue by Application (2027-2032) & (US$ Million) Table 212. China Drugs for Sexual Dysfunction Sales by Application (2021-2026) & (Units) Table 213. China Drugs for Sexual Dysfunction Sales by Application (2027-2032) & (Units) Table 214. China Drugs for Sexual Dysfunction Sales Price by Application (2021-2026) & (US$/Unit) Table 215. China Drugs for Sexual Dysfunction Sales Price by Application (2027-2032) & (US$/Unit) Table 216. Asia Drugs for Sexual Dysfunction Revenue by Type (2021-2026) & (US$ Million) Table 217. Asia Drugs for Sexual Dysfunction Revenue by Type (2027-2032) & (US$ Million) Table 218. Asia Drugs for Sexual Dysfunction Sales by Type (2021-2026) & (Units) Table 219. Asia Drugs for Sexual Dysfunction Sales by Type (2027-2032) & (Units) Table 220. Asia Drugs for Sexual Dysfunction Sales Price by Type (2021-2026) & (US$/Unit) Table 221. Asia Drugs for Sexual Dysfunction Sales Price by Type (2027-2032) & (US$/Unit) Table 222. Asia Drugs for Sexual Dysfunction Revenue by Application (2021-2026) & (US$ Million) Table 223. Asia Drugs for Sexual Dysfunction Revenue by Application (2027-2032) & (US$ Million) Table 224. Asia Drugs for Sexual Dysfunction Sales by Application (2021-2026) & (Units) Table 225. Asia Drugs for Sexual Dysfunction Sales by Application (2027-2032) & (Units) Table 226. Asia Drugs for Sexual Dysfunction Sales Price by Application (2021-2026) & (US$/Unit) Table 227. Asia Drugs for Sexual Dysfunction Sales Price by Application (2027-2032) & (US$/Unit) Table 228. Asia Drugs for Sexual Dysfunction Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 229. Asia Drugs for Sexual Dysfunction Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 230. Asia Drugs for Sexual Dysfunction Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 231. Asia Drugs for Sexual Dysfunction Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 232. Asia Drugs for Sexual Dysfunction Sales by Country (2021-2026) & (Units) Table 233. Asia Drugs for Sexual Dysfunction Sales by Country (2027-2032) & (Units) Table 234. Asia Drugs for Sexual Dysfunction Sales Price by Country (2021-2026) & (US$/Unit) Table 235. Asia Drugs for Sexual Dysfunction Sales Price by Country (2027-2032) & (US$/Unit) Table 236. Japan Drugs for Sexual Dysfunction Revenue (2021-2032) & (US$ Million) Table 237. South Korea Drugs for Sexual Dysfunction Revenue (2021-2032) & (US$ Million) Table 238. India Drugs for Sexual Dysfunction Revenue (2021-2032) & (US$ Million) Table 239. Australia Drugs for Sexual Dysfunction Revenue (2021-2032) & (US$ Million) Table 240. Taiwan Drugs for Sexual Dysfunction Revenue (2021-2032) & (US$ Million) Table 241. Southeast Asia Drugs for Sexual Dysfunction Revenue (2021-2032) & (US$ Million) Table 242. SAMEA Drugs for Sexual Dysfunction Revenue by Type (2021-2026) & (US$ Million) Table 243. SAMEA Drugs for Sexual Dysfunction Revenue by Type (2027-2032) & (US$ Million) Table 244. SAMEA Drugs for Sexual Dysfunction Sales by Type (2021-2026) & (Units) Table 245. SAMEA Drugs for Sexual Dysfunction Sales by Type (2027-2032) & (Units) Table 246. SAMEA Drugs for Sexual Dysfunction Sales Price by Type (2021-2026) & (US$/Unit) Table 247. SAMEA Drugs for Sexual Dysfunction Sales Price by Type (2027-2032) & (US$/Unit) Table 248. SAMEA Drugs for Sexual Dysfunction Revenue by Application (2021-2026) & (US$ Million) Table 249. SAMEA Drugs for Sexual Dysfunction Revenue by Application (2027-2032) & (US$ Million) Table 250. SAMEA Drugs for Sexual Dysfunction Sales by Application (2021-2026) & (Units) Table 251. SAMEA Drugs for Sexual Dysfunction Sales by Application (2027-2032) & (Units) Table 252. SAMEA Drugs for Sexual Dysfunction Sales Price by Application (2021-2026) & (US$/Unit) Table 253. SAMEA Drugs for Sexual Dysfunction Sales Price by Application (2027-2032) & (US$/Unit) Table 254. SAMEA Drugs for Sexual Dysfunction Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 255. SAMEA Drugs for Sexual Dysfunction Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 256. SAMEA Drugs for Sexual Dysfunction Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 257. SAMEA Drugs for Sexual Dysfunction Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 258. SAMEA Drugs for Sexual Dysfunction Sales by Country (2021-2026) & (Units) Table 259. SAMEA Drugs for Sexual Dysfunction Sales by Country (2027-2032) & (Units) Table 260. SAMEA Drugs for Sexual Dysfunction Sales Price by Country (2021-2026) & (US$/Unit) Table 261. SAMEA Drugs for Sexual Dysfunction Sales Price by Country (2027-2032) & (US$/Unit) Table 262. Brazil Drugs for Sexual Dysfunction Revenue (2021-2032) & (US$ Million) Table 263. Argentina Drugs for Sexual Dysfunction Revenue (2021-2032) & (US$ Million) Table 264. Chile Drugs for Sexual Dysfunction Revenue (2021-2032) & (US$ Million) Table 265. Colombia Drugs for Sexual Dysfunction Revenue (2021-2032) & (US$ Million) Table 266. Peru Drugs for Sexual Dysfunction Revenue (2021-2032) & (US$ Million) Table 267. Saudi Arabia Drugs for Sexual Dysfunction Revenue (2021-2032) & (US$ Million) Table 268. Israel Drugs for Sexual Dysfunction Revenue (2021-2032) & (US$ Million) Table 269. UAE Drugs for Sexual Dysfunction Revenue (2021-2032) & (US$ Million) Table 270. Turkey Drugs for Sexual Dysfunction Revenue (2021-2032) & (US$ Million) Table 271. Iran Drugs for Sexual Dysfunction Revenue (2021-2032) & (US$ Million) Table 272. Egypt Drugs for Sexual Dysfunction Revenue (2021-2032) & (US$ Million) Table 273. Key Raw Materials Table 274. Raw Materials Key Suppliers Table 275. Drugs for Sexual Dysfunction Distributors List Table 276. Drugs for Sexual Dysfunction Customers List Table 277. Research Programs/Design for This Report Table 278. Authors List of This Report Table 279. Secondary Sources Table 280. Primary Sources List of Figures Figure 1. Drugs for Sexual Dysfunction Image Figure 2. Global Drugs for Sexual Dysfunction Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drugs for Sexual Dysfunction Market Size Share 2021 VS 2025 VS 2032 Figure 4. Vardenafil (Levitra, Staxyn) Image Figure 5. Tadalafil (Cialis) Image Figure 6. Udenafil (Zydena) Image Figure 7. Sildenafil (Viagra) Image Figure 8. Others Image Figure 9. Global Drugs for Sexual Dysfunction Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Drugs for Sexual Dysfunction Market Size Share 2021 VS 2025 VS 2032 Figure 11. Retail Pharmacies Image Figure 12. Online Pharmacies Image Figure 13. Hospitals Image Figure 14. Clinics Image Figure 15. Global Drugs for Sexual Dysfunction Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Drugs for Sexual Dysfunction Revenue (2021-2032) & (US$ Million) Figure 17. Global Drugs for Sexual Dysfunction Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Drugs for Sexual Dysfunction Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Drugs for Sexual Dysfunction Revenue Market Share by Region (2021-2032) Figure 20. Global Drugs for Sexual Dysfunction Sales (2021-2032) & (Units) Figure 21. Global Drugs for Sexual Dysfunction Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 22. Global Drugs for Sexual Dysfunction Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Drugs for Sexual Dysfunction Sales YoY (2021-2032) & (Units) Figure 24. Europe Drugs for Sexual Dysfunction Sales YoY (2021-2032) & (Units) Figure 25. China Drugs for Sexual Dysfunction Sales YoY (2021-2032) & (Units) Figure 26. Asia (Excluding China) Drugs for Sexual Dysfunction Sales YoY (2021-2032) & (Units) Figure 27. South America, Middle East and Africa Drugs for Sexual Dysfunction Sales YoY (2021-2032) & (Units) Figure 28. Global Drugs for Sexual Dysfunction Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Drugs for Sexual Dysfunction Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Drugs for Sexual Dysfunction Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Drugs for Sexual Dysfunction Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Drugs for Sexual Dysfunction Revenue Market Share by Type (2021-2032) Figure 34. Global Drugs for Sexual Dysfunction Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 35. Global Drugs for Sexual Dysfunction Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Drugs for Sexual Dysfunction Sales Market Share by Type (2021-2032) Figure 37. Global Drugs for Sexual Dysfunction Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Drugs for Sexual Dysfunction Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Drugs for Sexual Dysfunction Revenue Market Share by Application (2021-2032) Figure 40. Global Drugs for Sexual Dysfunction Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 41. Global Drugs for Sexual Dysfunction Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Drugs for Sexual Dysfunction Sales Market Share by Application (2021-2032) Figure 43. North America Drugs for Sexual Dysfunction Revenue Share by Type (2021-2032) Figure 44. North America Drugs for Sexual Dysfunction Sales Share by Type (2021-2032) Figure 45. North America Drugs for Sexual Dysfunction Revenue Share by Application (2021-2032) Figure 46. North America Drugs for Sexual Dysfunction Sales Share by Application (2021-2032) Figure 47. North America Drugs for Sexual Dysfunction Revenue Share by Country (2021-2032) Figure 48. North America Drugs for Sexual Dysfunction Sales Share by Country (2021-2032) Figure 49. Europe Drugs for Sexual Dysfunction Revenue Share by Type (2021-2032) Figure 50. Europe Drugs for Sexual Dysfunction Sales Share by Type (2021-2032) Figure 51. Europe Drugs for Sexual Dysfunction Revenue Share by Application (2021-2032) Figure 52. Europe Drugs for Sexual Dysfunction Sales Share by Application (2021-2032) Figure 53. Europe Drugs for Sexual Dysfunction Revenue Share by Country (2021-2032) Figure 54. Europe Drugs for Sexual Dysfunction Sales Share by Country (2021-2032) Figure 55. China Drugs for Sexual Dysfunction Revenue Share by Type (2021-2032) Figure 56. China Drugs for Sexual Dysfunction Sales Share by Type (2021-2032) Figure 57. China Drugs for Sexual Dysfunction Revenue Share by Application (2021-2032) Figure 58. China Drugs for Sexual Dysfunction Sales Share by Application (2021-2032) Figure 59. Asia Drugs for Sexual Dysfunction Revenue Share by Type (2021-2032) Figure 60. Asia Drugs for Sexual Dysfunction Sales Share by Type (2021-2032) Figure 61. Asia Drugs for Sexual Dysfunction Revenue Share by Application (2021-2032) Figure 62. Asia Drugs for Sexual Dysfunction Sales Share by Application (2021-2032) Figure 63. Asia Drugs for Sexual Dysfunction Revenue Share by Country (2021-2032) Figure 64. Asia Drugs for Sexual Dysfunction Sales Share by Country (2021-2032) Figure 65. SAMEA Drugs for Sexual Dysfunction Revenue Share by Type (2021-2032) Figure 66. SAMEA Drugs for Sexual Dysfunction Sales Share by Type (2021-2032) Figure 67. SAMEA Drugs for Sexual Dysfunction Revenue Share by Application (2021-2032) Figure 68. SAMEA Drugs for Sexual Dysfunction Sales Share by Application (2021-2032) Figure 69. SAMEA Drugs for Sexual Dysfunction Revenue Share by Country (2021-2032) Figure 70. SAMEA Drugs for Sexual Dysfunction Sales Share by Country (2021-2032) Figure 71. Drugs for Sexual Dysfunction Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Drugs for Sexual Dysfunction Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Vardenafil (Levitra, Staxyn)
  • Tadalafil (Cialis)
  • Udenafil (Zydena)
  • Sildenafil (Viagra)
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospitals
  • Clinics
Companies covered
  • Boston Scientific Corporation
  • CSBio
  • Dong-A ST
  • General Factory
  • Hims
  • Lilly ICOS LLC
  • Lupin
  • Meda Pharmaceuticals
  • Menarini Group
  • Metuchen Pharma
  • SK Chemicals.
  • Vivus, Inc.
  • Bayer AG
  • Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
  • Pfizer Inc
  • Lilly
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Drugs for Sexual Dysfunction Market by Type
  3. 1.2.1 Global Drugs for Sexual Dysfunction Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Vardenafil (Levitra, Staxyn)
  5. 1.2.3 Tadalafil (Cialis)
  6. 1.2.4 Udenafil (Zydena)
  7. 1.2.5 Sildenafil (Viagra)
  8. 1.2.6 Others
  9. 1.3 Drugs for Sexual Dysfunction Market by Application
  10. 1.3.1 Global Drugs for Sexual Dysfunction Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Retail Pharmacies
  12. 1.3.3 Online Pharmacies
  13. 1.3.4 Hospitals
  14. 1.3.5 Clinics
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Drugs for Sexual Dysfunction Market Dynamics
  1. 2.1 Drugs for Sexual Dysfunction Industry Trends
  2. 2.2 Drugs for Sexual Dysfunction Industry Drivers
  3. 2.3 Drugs for Sexual Dysfunction Industry Opportunities and Challenges
  4. 2.4 Drugs for Sexual Dysfunction Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Drugs for Sexual Dysfunction Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Drugs for Sexual Dysfunction Revenue by Region
  3. 3.2.1 Global Drugs for Sexual Dysfunction Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Drugs for Sexual Dysfunction Revenue by Region (2021-2026)
  5. 3.2.3 Global Drugs for Sexual Dysfunction Revenue by Region (2027-2032)
  6. 3.2.4 Global Drugs for Sexual Dysfunction Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Drugs for Sexual Dysfunction Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Drugs for Sexual Dysfunction Sales by Region
  9. 3.4.1 Global Drugs for Sexual Dysfunction Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Drugs for Sexual Dysfunction Sales by Region (2021-2026)
  11. 3.4.3 Global Drugs for Sexual Dysfunction Sales by Region (2027-2032)
  12. 3.4.4 Global Drugs for Sexual Dysfunction Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Drugs for Sexual Dysfunction Revenue by Manufacturers
  2. 4.1.1 Global Drugs for Sexual Dysfunction Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Drugs for Sexual Dysfunction Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Drugs for Sexual Dysfunction Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Drugs for Sexual Dysfunction Sales by Manufacturers
  6. 4.2.1 Global Drugs for Sexual Dysfunction Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Drugs for Sexual Dysfunction Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Drugs for Sexual Dysfunction Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Drugs for Sexual Dysfunction Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Drugs for Sexual Dysfunction Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Drugs for Sexual Dysfunction Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Drugs for Sexual Dysfunction Manufacturers, Product Type & Application
  13. 4.7 Global Drugs for Sexual Dysfunction Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Drugs for Sexual Dysfunction Market CR5 and HHI
  16. 4.8.2 2025 Drugs for Sexual Dysfunction Tier 1, Tier 2, and Tier 3
5 Drugs for Sexual Dysfunction Market by Type
  1. 5.1 Global Drugs for Sexual Dysfunction Revenue by Type
  2. 5.1.1 Global Drugs for Sexual Dysfunction Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Drugs for Sexual Dysfunction Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Drugs for Sexual Dysfunction Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Drugs for Sexual Dysfunction Sales by Type
  6. 5.2.1 Global Drugs for Sexual Dysfunction Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Drugs for Sexual Dysfunction Sales by Type (2021-2032) & (Units)
  8. 5.2.3 Global Drugs for Sexual Dysfunction Sales Market Share by Type (2021-2032)
  9. 5.3 Global Drugs for Sexual Dysfunction Price by Type
6 Drugs for Sexual Dysfunction Market by Application
  1. 6.1 Global Drugs for Sexual Dysfunction Revenue by Application
  2. 6.1.1 Global Drugs for Sexual Dysfunction Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Drugs for Sexual Dysfunction Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Drugs for Sexual Dysfunction Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Drugs for Sexual Dysfunction Sales by Application
  6. 6.2.1 Global Drugs for Sexual Dysfunction Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Drugs for Sexual Dysfunction Sales by Application (2021-2032) & (Units)
  8. 6.2.3 Global Drugs for Sexual Dysfunction Sales Market Share by Application (2021-2032)
  9. 6.3 Global Drugs for Sexual Dysfunction Price by Application
7 Company Profiles
  1. 7.1 Boston Scientific Corporation
  2. 7.1.1 Boston Scientific Corporation Company Information
  3. 7.1.2 Boston Scientific Corporation Business Overview
  4. 7.1.3 Boston Scientific Corporation Drugs for Sexual Dysfunction Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Boston Scientific Corporation Drugs for Sexual Dysfunction Product Portfolio
  6. 7.1.5 Boston Scientific Corporation Recent Developments
  7. 7.2 CSBio
  8. 7.2.1 CSBio Company Information
  9. 7.2.2 CSBio Business Overview
  10. 7.2.3 CSBio Drugs for Sexual Dysfunction Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 CSBio Drugs for Sexual Dysfunction Product Portfolio
  12. 7.2.5 CSBio Recent Developments
  13. 7.3 Dong-A ST
  14. 7.3.1 Dong-A ST Company Information
  15. 7.3.2 Dong-A ST Business Overview
  16. 7.3.3 Dong-A ST Drugs for Sexual Dysfunction Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Dong-A ST Drugs for Sexual Dysfunction Product Portfolio
  18. 7.3.5 Dong-A ST Recent Developments
  19. 7.4 General Factory
  20. 7.4.1 General Factory Company Information
  21. 7.4.2 General Factory Business Overview
  22. 7.4.3 General Factory Drugs for Sexual Dysfunction Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 General Factory Drugs for Sexual Dysfunction Product Portfolio
  24. 7.4.5 General Factory Recent Developments
  25. 7.5 Hims
  26. 7.5.1 Hims Company Information
  27. 7.5.2 Hims Business Overview
  28. 7.5.3 Hims Drugs for Sexual Dysfunction Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Hims Drugs for Sexual Dysfunction Product Portfolio
  30. 7.5.5 Hims Recent Developments
  31. 7.6 Lilly ICOS LLC
  32. 7.6.1 Lilly ICOS LLC Company Information
  33. 7.6.2 Lilly ICOS LLC Business Overview
  34. 7.6.3 Lilly ICOS LLC Drugs for Sexual Dysfunction Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Lilly ICOS LLC Drugs for Sexual Dysfunction Product Portfolio
  36. 7.6.5 Lilly ICOS LLC Recent Developments
  37. 7.7 Lupin
  38. 7.7.1 Lupin Company Information
  39. 7.7.2 Lupin Business Overview
  40. 7.7.3 Lupin Drugs for Sexual Dysfunction Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Lupin Drugs for Sexual Dysfunction Product Portfolio
  42. 7.7.5 Lupin Recent Developments
  43. 7.8 Meda Pharmaceuticals
  44. 7.8.1 Meda Pharmaceuticals Company Information
  45. 7.8.2 Meda Pharmaceuticals Business Overview
  46. 7.8.3 Meda Pharmaceuticals Drugs for Sexual Dysfunction Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Meda Pharmaceuticals Drugs for Sexual Dysfunction Product Portfolio
  48. 7.8.5 Meda Pharmaceuticals Recent Developments
  49. 7.9 Menarini Group
  50. 7.9.1 Menarini Group Company Information
  51. 7.9.2 Menarini Group Business Overview
  52. 7.9.3 Menarini Group Drugs for Sexual Dysfunction Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Menarini Group Drugs for Sexual Dysfunction Product Portfolio
  54. 7.9.5 Menarini Group Recent Developments
  55. 7.10 Metuchen Pharma
  56. 7.10.1 Metuchen Pharma Company Information
  57. 7.10.2 Metuchen Pharma Business Overview
  58. 7.10.3 Metuchen Pharma Drugs for Sexual Dysfunction Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Metuchen Pharma Drugs for Sexual Dysfunction Product Portfolio
  60. 7.10.5 Metuchen Pharma Recent Developments
  61. 7.11 SK Chemicals.
  62. 7.11.1 SK Chemicals. Company Information
  63. 7.11.2 SK Chemicals. Business Overview
  64. 7.11.3 SK Chemicals. Drugs for Sexual Dysfunction Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 SK Chemicals. Drugs for Sexual Dysfunction Product Portfolio
  66. 7.11.5 SK Chemicals. Recent Developments
  67. 7.12 Vivus, Inc.
  68. 7.12.1 Vivus, Inc. Company Information
  69. 7.12.2 Vivus, Inc. Business Overview
  70. 7.12.3 Vivus, Inc. Drugs for Sexual Dysfunction Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Vivus, Inc. Drugs for Sexual Dysfunction Product Portfolio
  72. 7.12.5 Vivus, Inc. Recent Developments
  73. 7.13 Bayer AG
  74. 7.13.1 Bayer AG Company Information
  75. 7.13.2 Bayer AG Business Overview
  76. 7.13.3 Bayer AG Drugs for Sexual Dysfunction Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Bayer AG Drugs for Sexual Dysfunction Product Portfolio
  78. 7.13.5 Bayer AG Recent Developments
  79. 7.14 Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
  80. 7.14.1 Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Company Information
  81. 7.14.2 Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Business Overview
  82. 7.14.3 Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Drugs for Sexual Dysfunction Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Drugs for Sexual Dysfunction Product Portfolio
  84. 7.14.5 Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Recent Developments
  85. 7.15 Pfizer Inc
  86. 7.15.1 Pfizer Inc Company Information
  87. 7.15.2 Pfizer Inc Business Overview
  88. 7.15.3 Pfizer Inc Drugs for Sexual Dysfunction Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Pfizer Inc Drugs for Sexual Dysfunction Product Portfolio
  90. 7.15.5 Pfizer Inc Recent Developments
  91. 7.16 Lilly
  92. 7.16.1 Lilly Company Information
  93. 7.16.2 Lilly Business Overview
  94. 7.16.3 Lilly Drugs for Sexual Dysfunction Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Lilly Drugs for Sexual Dysfunction Product Portfolio
  96. 7.16.5 Lilly Recent Developments
  97. 7.17 Sanofi
  98. 7.17.1 Sanofi Company Information
  99. 7.17.2 Sanofi Business Overview
  100. 7.17.3 Sanofi Drugs for Sexual Dysfunction Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Sanofi Drugs for Sexual Dysfunction Product Portfolio
  102. 7.17.5 Sanofi Recent Developments
  103. 7.18 Teva Pharmaceutical Industries Ltd.
  104. 7.18.1 Teva Pharmaceutical Industries Ltd. Company Information
  105. 7.18.2 Teva Pharmaceutical Industries Ltd. Business Overview
  106. 7.18.3 Teva Pharmaceutical Industries Ltd. Drugs for Sexual Dysfunction Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Teva Pharmaceutical Industries Ltd. Drugs for Sexual Dysfunction Product Portfolio
  108. 7.18.5 Teva Pharmaceutical Industries Ltd. Recent Developments
8 North America
  1. 8.1 North America Drugs for Sexual Dysfunction Market Size by Type
  2. 8.1.1 North America Drugs for Sexual Dysfunction Revenue by Type (2021-2032)
  3. 8.1.2 North America Drugs for Sexual Dysfunction Sales by Type (2021-2032)
  4. 8.1.3 North America Drugs for Sexual Dysfunction Price by Type (2021-2032)
  5. 8.2 North America Drugs for Sexual Dysfunction Market Size by Application
  6. 8.2.1 North America Drugs for Sexual Dysfunction Revenue by Application (2021-2032)
  7. 8.2.2 North America Drugs for Sexual Dysfunction Sales by Application (2021-2032)
  8. 8.2.3 North America Drugs for Sexual Dysfunction Price by Application (2021-2032)
  9. 8.3 North America Drugs for Sexual Dysfunction Market Size by Country
  10. 8.3.1 North America Drugs for Sexual Dysfunction Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Drugs for Sexual Dysfunction Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Drugs for Sexual Dysfunction Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Drugs for Sexual Dysfunction Market Size by Type
  2. 9.1.1 Europe Drugs for Sexual Dysfunction Revenue by Type (2021-2032)
  3. 9.1.2 Europe Drugs for Sexual Dysfunction Sales by Type (2021-2032)
  4. 9.1.3 Europe Drugs for Sexual Dysfunction Price by Type (2021-2032)
  5. 9.2 Europe Drugs for Sexual Dysfunction Market Size by Application
  6. 9.2.1 Europe Drugs for Sexual Dysfunction Revenue by Application (2021-2032)
  7. 9.2.2 Europe Drugs for Sexual Dysfunction Sales by Application (2021-2032)
  8. 9.2.3 Europe Drugs for Sexual Dysfunction Price by Application (2021-2032)
  9. 9.3 Europe Drugs for Sexual Dysfunction Market Size by Country
  10. 9.3.1 Europe Drugs for Sexual Dysfunction Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Drugs for Sexual Dysfunction Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Drugs for Sexual Dysfunction Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Drugs for Sexual Dysfunction Market Size by Type
  2. 10.1.1 China Drugs for Sexual Dysfunction Revenue by Type (2021-2032)
  3. 10.1.2 China Drugs for Sexual Dysfunction Sales by Type (2021-2032)
  4. 10.1.3 China Drugs for Sexual Dysfunction Price by Type (2021-2032)
  5. 10.2 China Drugs for Sexual Dysfunction Market Size by Application
  6. 10.2.1 China Drugs for Sexual Dysfunction Revenue by Application (2021-2032)
  7. 10.2.2 China Drugs for Sexual Dysfunction Sales by Application (2021-2032)
  8. 10.2.3 China Drugs for Sexual Dysfunction Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Drugs for Sexual Dysfunction Market Size by Type
  2. 11.1.1 Asia Drugs for Sexual Dysfunction Revenue by Type (2021-2032)
  3. 11.1.2 Asia Drugs for Sexual Dysfunction Sales by Type (2021-2032)
  4. 11.1.3 Asia Drugs for Sexual Dysfunction Price by Type (2021-2032)
  5. 11.2 Asia Drugs for Sexual Dysfunction Market Size by Application
  6. 11.2.1 Asia Drugs for Sexual Dysfunction Revenue by Application (2021-2032)
  7. 11.2.2 Asia Drugs for Sexual Dysfunction Sales by Application (2021-2032)
  8. 11.2.3 Asia Drugs for Sexual Dysfunction Price by Application (2021-2032)
  9. 11.3 Asia Drugs for Sexual Dysfunction Market Size by Country
  10. 11.3.1 Asia Drugs for Sexual Dysfunction Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Drugs for Sexual Dysfunction Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Drugs for Sexual Dysfunction Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Drugs for Sexual Dysfunction Market Size by Type
  2. 12.1.1 SAMEA Drugs for Sexual Dysfunction Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Drugs for Sexual Dysfunction Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Drugs for Sexual Dysfunction Price by Type (2021-2032)
  5. 12.2 SAMEA Drugs for Sexual Dysfunction Market Size by Application
  6. 12.2.1 SAMEA Drugs for Sexual Dysfunction Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Drugs for Sexual Dysfunction Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Drugs for Sexual Dysfunction Price by Application (2021-2032)
  9. 12.3 SAMEA Drugs for Sexual Dysfunction Market Size by Country
  10. 12.3.1 SAMEA Drugs for Sexual Dysfunction Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Drugs for Sexual Dysfunction Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Drugs for Sexual Dysfunction Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Drugs for Sexual Dysfunction Value Chain Analysis
  2. 13.1.1 Drugs for Sexual Dysfunction Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Drugs for Sexual Dysfunction Production Mode & Process
  6. 13.2 Drugs for Sexual Dysfunction Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Drugs for Sexual Dysfunction Distributors
  9. 13.2.3 Drugs for Sexual Dysfunction Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst